Query: container closure integrity study methodology
Correspondence from Saudi Food and Drug Authority regarding SFDA-2023-0037. Type: question. Risk: high. Category: Nonclinical.
Correspondence ID
COR-237
Type
question
Application
Authority
Saudi Food and Drug Authority
Category
Nonclinical
Risk
High
Due Date
2025-04-19
Status
Overdue
Owner
Lieselotte van der Berg
Created
2022-09-30
Correspondence Body
Dear SFDA Review Team,
With reference to application SFDA-2023-0037, we wish to address the following:
[Detailed response body regarding query: container closure integrity study methodology]
We trust this information is satisfactory. Please do not hesitate to contact us for further clarification.
Kind regards,
KCL BioPharm Regulatory Affairs
Attachments
data_table_237.xlsxattachment_237_1.pdf
Response Assembly
Draft Response Actions:
Response deadline: 2025-04-19 — Assign relevant content components from the dossier and compile a response package using the Content Assembly Workbench.